Amending Title 35, United States Code, with respect to patents on certain processes: hearing before the Subcommittee on Intellectual Property and Judicial Administration of the Committee on the Judiciary, House of Representatives, One Hundred Third Congress, first session, on H.R. 760 ... June 9, 1993
What people are saying - Write a review
We haven't found any reviews in the usual places.
Kirk Michael K Acting Assistant Secretary and Acting Commissioner
LaFuze William I president American Intellectual Property
2 other sections not shown
Other editions - View all
Administration AIPLA amendments Amgen Armitage bill billion biotech biotechnology companies biotechnology industry biotechnology inventions Biotechnology Patent Protection biotechnology process Boucher CAFC California Chairman Chugai Committee competition Congress Corporation courts enactment end product erythropoietin Federal Circuit field of technology foreign competitors gene Genentech genetic engineering hearing Hughes human human growth hormone important innovation Intellectual Property inventors issue Kirk LaFuze legislation litigation manufacture McCollum Moorhead NAFTA obtain obvious Odre Patent and Trademark patent applications Patent Attorney Patent Counsel patent examiners Patent Office Patent Protection Act patent system patentable material pharmaceutical Pleuddemann problem process claims process invention process patent process patent protection product claims protein proteins U.S. Patent Raab recombinant rEPO result Rick Boucher section 103 Senate subcommittee terminal disclaimer Thank tion title 35 Trademark Office U.S. patent law unfair United United States Code Vice President